Worldwide Discovery Fund
Worldwide Discovery Fund
The Worldwide Discovery Fund aims to produce attractive long-term returns, mainly through capital growth. The Fund will invest primarily in equities which are listed, traded or dealt in on Regulated Markets worldwide and which will typically be stocks of smaller or younger companies that the Investment Manager considers to have strong future growth prospects.
PLEASE NOTE, THIS FUND IS CURRENTLY CLOSED TO NEW INVESTORS.
Performance & PortfolioData is not currently available for this share class.
Top Ten Holdings - 30/06/2021
Fund % 1 Ocado 5.6% 2 Zillow 4.4% 3 Tesla Inc 4.3% 4 Alnylam Pharmaceuticals 4.1% 5 Novocure 3.9% 6 STAAR Surgical 3.8% 7 MarketAxess 3.4% 8 Zai Lab 3.3% 9 Chegg 2.8% 10 Appian 2.8% Total 38.4%Geographic Analysis of Total Assets 30/06/2021
- 1 North America 63.94
- 2 UK 10.44
- 3 Emerging Markets 10.05
- 4 Developed Asia Pacific 7.24
- 5 Europe (ex UK) 4.33
- 6 Cash 4.00
- Total 100.0
As the Fund invests in overseas securities, changes in the rates of exchange may cause the value of your investment (and any income it may pay) to go down or up.
The information contained on this page is intended as a guide only and should not be relied upon when making investment decisions. All holdings information is unaudited. Source Baillie Gifford & Co.
Please note that totals may not add due to rounding.
Douglas joined Baillie Gifford in 2001 and is Head of the Global Discovery Team. Douglas became a Partner in 2015 and is a CFA Charterholder. He graduated BSc in Molecular Biology & Biochemistry from the University of Durham in 1997 and attained a DPhil in Molecular Immunology from the University of Oxford in 2001.
You can access any literature about the Fund here, either by downloading or requesting a copy by post (where available). Please note that, due to current government restrictions, we have a limited number of staff in our office. As a result, if posting instructions to us, there may be a delay in processing these due to these current restrictions.
To download any document you will need Adobe Reader. Please note that we can now provide you with Braille and audio transcriptions of our literature on request. It may take up to 10 days for the transcription to be completed dependent on the size of the document.
Key Investor Information Documents
MIFID II Ex-Ante Disclosures
Other Fund Literature
Philosophy and Process Documents
Quarterly Investor Updates
BAILLIE GIFFORD INVESTMENT MANAGEMENT (EUROPE) LIMITED: REGISTERED OFFICE
Baillie Gifford Investment Management (Europe) Limited is authorised and regulated by the Central Bank of Ireland (No. C182354). Registered office: 4/5 School House Lane East, Dublin 2, D02 N279. Registered in Ireland (No. 625892).COMPLAINTS CONTACT DETAILS
In the first instance, clients should contact their normal Client Contact with any concerns. Alternatively, or for those clients who do not have a direct client contact assigned, complaints can be emailed to Baillie Gifford’s Compliance Department at: InstitutionalComplaints@bailliegifford.com. A summary document which contains details on Baillie Gifford’s complaints management policy is available upon request. All material complaints are recorded in an in-house incident management system and are escalated to, and dealt with by, members of staff of suitable seniority, independent of the area from which the matter arose.